Abstract:OBJECTIVE: The aim of this study was to assess the efficacy and safety of intrapleural perfusion with hyperthermic chemotherapy (IPHC) in treating malignant pleural effusion (MPE) compared to normothermic chemoperfusion of the pleural cavity (NCPC), and to investigate the better treatment to control MPE.METHODS: Malignant pleural effusion patients were enrolled in the study and treated with NCPC or IPHC under video-assisted thoracoscopic surgery (VATS). The chest drainage duration, clinical characteristics, and recurrence time of pleural effusion of patients were collected for statistical analysis. The chi-squared test and the Fisher's exact test were applied to compare the distribution differences in categorical variables. Progression-free survival (PFS) was estimated by the Kaplan-Meier method and was compared by the log-rank test. The survival analysis was performed using the Cox proportional hazards method.RESULTS: A total of 37 MPE patients were enrolled in this study. Twenty-seven patients received NCPC and 10 patients received IPHC under VATS. Significant differences were found in pathological types (p = 0.011), chest drainage duration (p = 0.005), and remission rate (p = 0.009) between two different treatment groups. The chest drainage duration of IPHC under VATS was shorter than the NCPC group (t = 2.969, p = 0.005). The remission rate of MPE in IPHC group was better than the NCPC one (OR = 0.031, 95% CI: 0.002-0.507, p = 0.015). The result of the Kaplan-Meier method showed that IPHC group could significantly prolong the PFS of patients with MPE compared to NCPC group (log-rank p = 0.002). Univariate cox regression analysis showed that patients with MPE in the IPHC group presented significant longer PFS than the NCPC group (HR = 0.264, 95% CI: 0.098-0.713, p = 0.009). Multivariate cox regression analysis further verified this conclusion (HR = 0.268, 95% CI: 0.096-0.753, p = 0.012).CONCLUSION: Compared to the NCPC, the IPHC under VATS presents a better control effect on MPE, shorter tube placement time, and longer complete remission time. For this reason, we recommend IPHC under VATS as the first-line treatment for patients with MPE those who can tolerate minimally invasive surgery.

Clinical Observation on Treatment of Malignant Pleural Efusion Caused by Iung Cancer with Intracavity Drainage Plus Perfusion Medication

Treatment of Malignant Pleural Effusion with Radiofrequency Hyperthermia Combined with Intravenous Chemotherapy and Intrapleural Injection

The study of pleural lavage cytology for lung cancer

Elemene,bleomycin,as well as the two drugs in the treatment of malignant pleural effusion clinical observation

Therapeutical Effect of Intrapleural Perfusion with Hyperthermic Chemotherapy on Malignant Pleural Effusion under Video-Assisted Thoracoscopic Surgery

Intrapleural treatment in patients with non‐small cell lung cancer with malignant pleural effusions in the real world

Therapeutic Effect of Tumor Infiltrating Lymphocyte Plus Interleukin-2 Intrapleural Injection on Advanced Cancer Patients with Malignant Pleural Effusion

Better effect of intrapleural perfusion with hyperthermic chemotherapy by video‐assisted thoracoscopic surgery for malignant pleural effusion treatment compared to normothermic chemoperfusion of the pleural cavity

Association of lipids, lipoproteins, apolipoproteins and paraoxonase enzyme activity with premature coronary artery disease

The effect of whole pleural cavity irradiation with combined 60Co and electron beam plus local biological agents on malignant pleural effusion

Effect of Interleukin-2 and PDD in Treatment of Malignant Pleural Effu Sion

Current status of and progress in the treatment of malignant pleural effusion of lung cancer

Clinical Characteristics and Prognostic Factors in Breast Cancer with Malignant Pleural Effusion

Effect of bevacizumab on angiogenesis and related cytokines in mice with malignant pleural effusion

Effect of Hyperthermic Intrathoracic Chemotherapy (HITHOC) on the Malignant Pleural Effusion

Clinical Analysis of Inserting Abel Central Venous Catheter into Pleural Cavity and Interrupted Pleural Cavity Puncture to Draw Pleural Effusion in the Treatment of Patients with Malignant Pleural Effusion

Fiberoptic Bronchoscopy for the Diagnosis and Treatment of Malignant Pleural Effusion

Clinical effect of highly agglutinative staphylococcin combined with cisplatin in treatment of malignant pleural effusion

Efficacy Study of Hyperthermotherapy Combined with Cisplatin Injected into Thoracic Cavity in the Treatment of Pleural Effusion from Malignant Neoplams

Effect of Hyperthermic Intrathoracic Chemotherapy (hithoc) on the Malignant Pleural Effusion A Systematic Review and Meta-Analysis

Effect of domestic paclitaxel combined with external high frequency thermotherapy on malignant peritoneal effusion